NUTX vs. EVTC, FIVN, ALIT, LZ, OLO, ACVA, RAMP, DGNX, VVX, and ASTH
Should you be buying Nutex Health stock or one of its competitors? The main competitors of Nutex Health include Evertec (EVTC), Five9 (FIVN), Alight (ALIT), LegalZoom.com (LZ), OLO (OLO), ACV Auctions (ACVA), LiveRamp (RAMP), Diginex (DGNX), V2X (VVX), and Astrana Health (ASTH). These companies are all part of the "business services" industry.
Nutex Health vs. Its Competitors
Nutex Health (NASDAQ:NUTX) and Evertec (NYSE:EVTC) are both business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.
Evertec has a net margin of 15.56% compared to Nutex Health's net margin of 10.76%. Nutex Health's return on equity of 42.08% beat Evertec's return on equity.
Nutex Health presently has a consensus price target of $252.50, suggesting a potential upside of 162.72%. Evertec has a consensus price target of $39.00, suggesting a potential upside of 15.93%. Given Nutex Health's stronger consensus rating and higher probable upside, research analysts plainly believe Nutex Health is more favorable than Evertec.
In the previous week, Nutex Health had 24 more articles in the media than Evertec. MarketBeat recorded 28 mentions for Nutex Health and 4 mentions for Evertec. Evertec's average media sentiment score of 0.50 beat Nutex Health's score of 0.00 indicating that Evertec is being referred to more favorably in the news media.
Evertec has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Evertec, indicating that it is currently the more affordable of the two stocks.
5.3% of Nutex Health shares are held by institutional investors. Comparatively, 96.8% of Evertec shares are held by institutional investors. 36.9% of Nutex Health shares are held by insiders. Comparatively, 0.6% of Evertec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Nutex Health has a beta of -0.17, meaning that its share price is 117% less volatile than the S&P 500. Comparatively, Evertec has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500.
Summary
Evertec beats Nutex Health on 9 of the 16 factors compared between the two stocks.
Get Nutex Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Nutex Health Competitors List
Related Companies and Tools
This page (NASDAQ:NUTX) was last updated on 9/20/2025 by MarketBeat.com Staff